We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

159 hedge funds and large institutions have $614M invested in Rigel Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 48 increasing their positions, 47 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

47% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 17

25% more capital invested

Capital invested by funds: $493M → $614M (+$121M)

5% more funds holding

Funds holding: 152 → 159 (+7)

2% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 47

0.16% less ownership

Funds ownership: 8.48% → 8.32% (-0.16%)

5% less call options, than puts

Call options by funds: $3.43M | Put options by funds: $3.61M

Holders
159
Holders Change
+7
Holders Change %
+4.61%
% of All Funds
2.77%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
25
Increased
48
Reduced
47
Closed
17
Calls
$3.43M
Puts
$3.61M
Net Calls
-$176K
Net Calls Change
-$219K

Top Buyers

Rank Fund Capital Flow
1
CS
Candriam SCA
Luxembourg
+$8.39M
2
GPP
Great Point Partners
Connecticut
+$5.66M
3
Millennium Management
Millennium Management
New York
+$3.59M
4
N
Nuveen
North Carolina
+$3.28M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$3.15M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$12.2M
2
TA
Tamarack Advisers
California
-$7.36M
3
State Street
State Street
Massachusetts
-$6.89M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$4.39M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.97M
Name Holding Trade Value Shares
Change 		Change in
Stake
CM
26
CM Management
Florida
$3.25M +$944K +25,000 +50%
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$3.15M -$4.39M -116,370 -62%
RCMNY
28
Rubric Capital Management (New York)
New York
$2.88M +$2.51M +66,386 New
PAI
29
Palo Alto Investors
California
$2.83M – – –
Citigroup
30
Citigroup
New York
$2.77M -$513K -13,583 -18%
PAM
31
Panagora Asset Management
Massachusetts
$2.69M -$2.26M -59,839 -49%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$2.22M -$405K -10,722 -17%
Two Sigma Investments
33
Two Sigma Investments
New York
$2.17M -$2.99M -79,085 -61%
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
$2.05M +$727K +19,255 +69%
Charles Schwab
35
Charles Schwab
California
$1.85M -$13.6K -360 -0.8%
Rafferty Asset Management
36
Rafferty Asset Management
New York
$1.79M -$805K -21,335 -34%
WMSA
37
Weiss Multi-Strategy Advisers
New York
$1.73M +$48.3K +1,278 +3%
Swiss National Bank
38
Swiss National Bank
Switzerland
$1.62M -$38.5K -1,020 -3%
SSA
39
Schonfeld Strategic Advisors
New York
$1.53M +$1.33M +35,333 New
Bank of Montreal
40
Bank of Montreal
Ontario, Canada
$1.51M +$325K +8,608 +35%
DCM
41
Driehaus Capital Management
Illinois
$1.49M +$1.29M +34,300 New
AG
42
Artal Group
Luxembourg
$1.39M – – –
JGC
43
J. Goldman & Co
New York
$1.38M +$1.02M +27,023 +560%
State of Wisconsin Investment Board
44
State of Wisconsin Investment Board
Wisconsin
$1.34M +$302K +7,990 +35%
UBS AM
45
UBS AM
Illinois
$1.32M +$4.61K +122 +0.4%
Bank of America
46
Bank of America
North Carolina
$1.29M +$290K +7,670 +35%
Los Angeles Capital Management
47
Los Angeles Capital Management
California
$1.19M -$46.8K -1,239 -4%
GTCM
48
Gyon Technologies Capital Management
New Jersey
$1.15M +$998K +26,433 New
OC
49
Oppenheimer & Co
New York
$1.14M +$747K +19,774 +308%
Squarepoint
50
Squarepoint
New York
$1.14M +$613K +16,237 +164%
1
2
3 4 5

RIGL Hedge Fund Activity: Q2 2021 in Review

159 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q2 2021, worth a combined $614M — up 25% from $493M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new RIGL positions and 17 closed out — a net gain of 8 holders — while 48 added to existing stakes and 47 trimmed.

The largest buyer was Candriam SCA, opening a new position worth an estimated $8.39M. The largest seller was Citadel Advisors, cutting an estimated $12.2M.

  • 159 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q2 2021, up from 152 in Q1 2021.
  • Funds reported $614M of Rigel Pharmaceuticals stock for Q2 2021, up 25% quarter-over-quarter.
  • 25 funds opened new Rigel Pharmaceuticals positions in Q2 2021 and 17 closed out, a net change of +8 holders.
  • The largest Rigel Pharmaceuticals buyer in Q2 2021 was Candriam SCA, an estimated $8.39M added.
  • The largest Rigel Pharmaceuticals seller in Q2 2021 was Citadel Advisors, an estimated $12.2M sold.

Based on aggregated 13F filings for Q2 2021.